Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 220 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 9 results:
Author [ Title(Desc)] Type Year
Filters: Author is Maitland-van der Zee, A. H.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
O. A. Oshagbemi, Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., and de Vries, F., “Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)”, Copd, pp. 1-8, 2019.
O. A. Oshagbemi, Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., van der Zee, A. H. Maitlan, Burden, A. M., and de Vries, F., “Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1191-1199, 2018.
C
O. A. Oshagbemi, Franssen, F. M. E., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., de Boer, A., and de Vries, F., “C-reactive protein as a biomarker of response to inhaled corticosteroids among patients with COPD”, Pulm Pharmacol Ther, p. 101870, 2019.
D
S. H. Mahmoudpour, Baranova, E. V., Souverein, P. C., Asselbergs, F. W., de Boer, A., and van der Zee, A. H. Maitlan, “Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 82, pp. 1647-1659, 2016.
P
J. S. Floyd, Bloch, K. M., Brody, J. A., Maroteau, C., Siddiqui, M. K., Gregory, R., Carr, D. F., Molokhia, M., Liu, X., Bis, J. C., Ahmed, A., Liu, X., Hallberg, P., Yue, Q. Y., Magnusson, P. K. E., Brisson, D., Wiggins, K. L., Morrison, A. C., Khoury, E., McKeigue, P., Stricker, B. H., Lapeyre-Mestre, M., Heckbert, S. R., Gallagher, A. M., Chinoy, H., Gibbs, R. A., Bondon-Guitton, E., Tracy, R., Boerwinkle, E., Gaudet, D., Conforti, A., Van Staa, T., Sitlani, C. M., Rice, K. M., van der Zee, A. H. Maitlan, Wadelius, M., Morris, A. P., Pirmohamed, M., Palmer, C. A. N., Psaty, B. M., and Alfirevic, A., “Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing”, PLoS One, vol. 14, p. e0218115, 2019.
S. H. Mahmoudpour, Asselbergs, F. W., Souverein, P. C., de Boer, A., and van der Zee, A. H. Maitlan, “Prescription patterns of angiotensin-converting enzyme inhibitors for various indications: A UK population-based study”, Br J Clin Pharmacol, vol. 84, pp. 2365-2372, 2018.
R
Y. Zhang, Souverein, P. C., Gardarsdottir, H., van den Ham, H. A., van der Zee, A. H. Maitlan, and de Boer, A., “Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study”, Br J Clin Pharmacol, 2020.
S
O. A. Oshagbemi, Burden, A. M., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., Driessen, J. H. M., van der Zee, A. H. Maitlan, de Vries, F., and Franssen, F. M. E., “Stability of Blood Eosinophils in Patients with Chronic Obstructive Pulmonary Disease and in Control Subjects, and the Impact of Sex, Age, Smoking, and Baseline Counts”, Am J Respir Crit Care Med, vol. 195, pp. 1402-1404, 2017.
U
F. Ahmadizar, Souverein, P., de Boer, A., and van der Zee, A. H. Maitlan, “Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use”, Br J Clin Pharmacol, vol. 84, pp. 776-785, 2018.
[Page last reviewed 4 March 2021]